EUVIMEDEUVIMED entdecken
Crossref

SNMMI Clinical Trials Network Research Series for Technologists: An Introduction to Conducting Theranostic Clinical Trials

Freddy Gonzalez, Peter J H Scott, Charlotte Denise Jeffers, S Cheenu Kappadath

Journal of Nuclear Medicine Technology · 2024

DOI: 10.2967/jnmt.123.266588 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Nuclear Medicine Technology, 2024. Verfasst von Freddy Gonzalez und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic Imaging, M.D. Anderson Cancer Center, Houston, Texas; jagonzalez1@mdanderson.org. Hauptthemen laut MEDLINE: Clinical Trials as Topic, Nuclear Medicine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This article is intended to introduce nuclear medicine technologists (NMTs) to the nuances of radiopharmaceutical therapy clinical trials. Here, we outline the potential roles and responsibilities of the NMT in clinical trials and provide context on different aspects of radionuclide therapy. The regulatory process involving investigational therapeutic radiopharmaceuticals is seldom taught to NMT students, nor is it included in the entry-level nuclear medicine certification examinations. Often, NMTs must spend significant time preparing for therapeutic clinical trials on their own, using multiple academic sources, seeking advice from various health care professionals, and reviewing numerous trial-specific manuals to recognize the detailed requirements. The emergence of theranostics has spurred an increase in the development of therapeutic radiopharmaceuticals. Investigators with a robust nuclear medicine background are required to help develop successful therapeutic clinical trials, and well-informed NMTs are crucial to the success of such trials. This article follows a series of previous publications from the Society of Nuclear Medicine and Molecular Imaging Clinical Trials Network research series for technologists and is intended to guide the investigational radiopharmaceutical landscape.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clinical Trials as TopicNuclear MedicineHumansPrecision MedicineRadiopharmaceuticalsSocieties, Medical

Stichwörter der Autor:innen

dosimetryinfusiontechnologisttheranostics

Substanzen

Radiopharmaceuticals

Autor:innen und Institutionen

  • Department of Diagnostic Imaging, M.D. Anderson Cancer Center, Houston, Texas; jagonzalez1@mdanderson.org.
  • Department of Radiology, University of Michigan, Ann Arbor, Michigan.
  • Department of Radiology, University of Alabama at Birmingham, Birmingham, Alabama; and.
  • Department of Imaging Physics, M.D. Anderson Cancer Center, Houston, Texas.

Zitieren

APA

Gonzalez, F., Scott, P. J. H., Jeffers, C. D., & Kappadath, S. C. (2024). SNMMI Clinical Trials Network Research Series for Technologists: An Introduction to Conducting Theranostic Clinical Trials. Journal of Nuclear Medicine Technology. https://doi.org/10.2967/jnmt.123.266588

Vancouver

Gonzalez F, Scott PJH, Jeffers CD, Kappadath SC. SNMMI Clinical Trials Network Research Series for Technologists: An Introduction to Conducting Theranostic Clinical Trials. Journal of Nuclear Medicine Technology. 2024. doi:10.2967/jnmt.123.266588

BibTeX
@article{Gonzalez2024,
  author = {Gonzalez, Freddy and Scott, Peter J H and Jeffers, Charlotte Denise and Kappadath, S Cheenu},
  title = {SNMMI Clinical Trials Network Research Series for Technologists: An Introduction to Conducting Theranostic Clinical Trials},
  journal = {Journal of Nuclear Medicine Technology},
  year = {2024},
  doi = {10.2967/jnmt.123.266588}
}
Kostenlos starten →